İnaktif aşı (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "İnaktif aşı" in Turkish language version.

refsWebsite

Global rank Turkish rank

10doi.org

2^nd place

4^th place

10nih.gov

4^th place

11^th place

8web.archive.org

1^st place

2worldcat.org

5^th place

8^th place

2vaccine-safety-training.org

low place

1archive.org

6^th place

1cdc.gov

218^th place

269^th place

1who.int

195^th place

162^nd place

1vaccines.gov

low place

1canada.ca

1,712^th place

4,961^st place

1sc.edu

5,559^th place

low place

archive.org

Petrovsky N, Aguilar JC (October 2004). "Vaccine adjuvants: current state and future trends". Immunology and Cell Biology. 82 (5): 488-496. doi:10.1111/j.0818-9641.2004.01272.x. PMID 15479434.

canada.ca

National Advisory Committee on Immunization (NACI) (May 2018). NACI literature review on the comparative effectiveness and immunogenicity of subunit and split virus inactivated influenza vaccines in adults 65 years of age and older. Government of Canada. ISBN 9780660264387. Cat.: HP40-213/2018E-PDF; Pub.: 180039. 17 Mayıs 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2023.

cdc.gov

Wodi AP, Morelli V. "Chapter 1: Principles of Vaccination" (PDF). Hall E, Wodi AP, Hamborsky J, Morelli V, Schilllie S (Ed.). Epidemiology and Prevention of Vaccine-Preventable Diseases (14.14yıl=2021 bas.). Washington, D.C.: Public Health Foundation, Centers for Disease Control and Prevention. 30 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2023.

doi.org

Petrovsky N, Aguilar JC (October 2004). "Vaccine adjuvants: current state and future trends". Immunology and Cell Biology. 82 (5): 488-496. doi:10.1111/j.0818-9641.2004.01272.x. PMID 15479434.
Plotkin SA, Plotkin SL (October 2011). "The development of vaccines: how the past led to the future". Nature Reviews. Microbiology (3 Ekim 2011 tarihinde yayınlandı). 9 (12): 889-893. doi:10.1038/nrmicro2668. PMID 21963800.
Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M (March 2018). "Understanding modern-day vaccines: what you need to know". Annals of Medicine. 50 (2): 110-120. doi:10.1080/07853890.2017.1407035. PMID 29172780.
Slifka MK, Amanna I (May 2014). "How advances in immunology provide insight into improving vaccine efficacy". Vaccine. 32 (25): 2948-2957. doi:10.1016/j.vaccine.2014.03.078. PMC 4096845 $2. PMID 24709587.
Pollard AJ, Bijker EM (February 2021). "A guide to vaccinology: from basic principles to new developments". Nature Reviews. Immunology. 21 (2): 83-100. doi:10.1038/s41577-020-00479-7. PMC 7754704 $2. PMID 33353987.
Karch CP, Burkhard P (November 2016). "Vaccine technologies: From whole organisms to rationally designed protein assemblies". Biochemical Pharmacology. 120: 1-14. doi:10.1016/j.bcp.2016.05.001. PMC 5079805 $2. PMID 27157411.
Sanders B, Koldijk M, Schuitemaker H (2015). "Inactivated Viral Vaccines". Vaccine Analysis: Strategies, Principles, and Control: 45-80. doi:10.1007/978-3-662-45024-6_2. ISBN 978-3-662-45023-9. PMC 7189890 $2.
Hotez, Peter J.; Bottazzi, Maria Elena (27 Ocak 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55-64. doi:10.1146/annurev-med-042420-113212. ISSN 0066-4219. PMID 34637324. 15 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Nisan 2022.
Chen J, Wang J, Zhang J, Ly H (2021). "Advances in Development and Application of Influenza Vaccines". Frontiers in Immunology. 12: 711997. doi:10.3389/fimmu.2021.711997. PMC 8313855 $2. PMID 34326849.
Clem AS (January 2011). "Fundamentals of vaccine immunology". Journal of Global Infectious Diseases. 3 (1): 73-78. doi:10.4103/0974-777X.77299. PMC 3068582 $2. PMID 21572612.

nih.gov

ncbi.nlm.nih.gov

Petrovsky N, Aguilar JC (October 2004). "Vaccine adjuvants: current state and future trends". Immunology and Cell Biology. 82 (5): 488-496. doi:10.1111/j.0818-9641.2004.01272.x. PMID 15479434.
Plotkin SA, Plotkin SL (October 2011). "The development of vaccines: how the past led to the future". Nature Reviews. Microbiology (3 Ekim 2011 tarihinde yayınlandı). 9 (12): 889-893. doi:10.1038/nrmicro2668. PMID 21963800.
Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M (March 2018). "Understanding modern-day vaccines: what you need to know". Annals of Medicine. 50 (2): 110-120. doi:10.1080/07853890.2017.1407035. PMID 29172780.
Slifka MK, Amanna I (May 2014). "How advances in immunology provide insight into improving vaccine efficacy". Vaccine. 32 (25): 2948-2957. doi:10.1016/j.vaccine.2014.03.078. PMC 4096845 $2. PMID 24709587.
Pollard AJ, Bijker EM (February 2021). "A guide to vaccinology: from basic principles to new developments". Nature Reviews. Immunology. 21 (2): 83-100. doi:10.1038/s41577-020-00479-7. PMC 7754704 $2. PMID 33353987.
Karch CP, Burkhard P (November 2016). "Vaccine technologies: From whole organisms to rationally designed protein assemblies". Biochemical Pharmacology. 120: 1-14. doi:10.1016/j.bcp.2016.05.001. PMC 5079805 $2. PMID 27157411.
Sanders B, Koldijk M, Schuitemaker H (2015). "Inactivated Viral Vaccines". Vaccine Analysis: Strategies, Principles, and Control: 45-80. doi:10.1007/978-3-662-45024-6_2. ISBN 978-3-662-45023-9. PMC 7189890 $2.
Hotez, Peter J.; Bottazzi, Maria Elena (27 Ocak 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55-64. doi:10.1146/annurev-med-042420-113212. ISSN 0066-4219. PMID 34637324. 15 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Nisan 2022.
Chen J, Wang J, Zhang J, Ly H (2021). "Advances in Development and Application of Influenza Vaccines". Frontiers in Immunology. 12: 711997. doi:10.3389/fimmu.2021.711997. PMC 8313855 $2. PMID 34326849.
Clem AS (January 2011). "Fundamentals of vaccine immunology". Journal of Global Infectious Diseases. 3 (1): 73-78. doi:10.4103/0974-777X.77299. PMC 3068582 $2. PMID 21572612.

sc.edu

pathmicro.med.sc.edu

Ghaffar A, Haqqi T. "Immunization". Immunology. The Board of Trustees of the University of South Carolina. 26 Şubat 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Mart 2009.

vaccine-safety-training.org

"Toxoid vaccines - WHO Vaccine Safety Basics". vaccine-safety-training.org. World Health Organization (WHO). 4 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Kasım 2021.
"Inactivated whole-cell (killed antigen) vaccines - WHO Vaccine Safety Basics". vaccine-safety-training.org. World Health Organization (WHO). 4 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Kasım 2021.

vaccines.gov

"Types of Vaccines". Vaccines.gov. U.S. Department of Health and Human Services. 23 Temmuz 2013. 9 Haziran 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Mayıs 2016.

web.archive.org

Wodi AP, Morelli V. "Chapter 1: Principles of Vaccination" (PDF). Hall E, Wodi AP, Hamborsky J, Morelli V, Schilllie S (Ed.). Epidemiology and Prevention of Vaccine-Preventable Diseases (14.14yıl=2021 bas.). Washington, D.C.: Public Health Foundation, Centers for Disease Control and Prevention. 30 Aralık 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2023.
WHO Expert Committee on Biological Standardization (19 Haziran 2019). "Influenza". World Health Organization (WHO). 22 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Ekim 2021.
"Types of Vaccines". Vaccines.gov. U.S. Department of Health and Human Services. 23 Temmuz 2013. 9 Haziran 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Mayıs 2016.
Hotez, Peter J.; Bottazzi, Maria Elena (27 Ocak 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55-64. doi:10.1146/annurev-med-042420-113212. ISSN 0066-4219. PMID 34637324. 15 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Nisan 2022.
National Advisory Committee on Immunization (NACI) (May 2018). NACI literature review on the comparative effectiveness and immunogenicity of subunit and split virus inactivated influenza vaccines in adults 65 years of age and older. Government of Canada. ISBN 9780660264387. Cat.: HP40-213/2018E-PDF; Pub.: 180039. 17 Mayıs 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 5 Nisan 2023.
"Toxoid vaccines - WHO Vaccine Safety Basics". vaccine-safety-training.org. World Health Organization (WHO). 4 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Kasım 2021.
Ghaffar A, Haqqi T. "Immunization". Immunology. The Board of Trustees of the University of South Carolina. 26 Şubat 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Mart 2009.
"Inactivated whole-cell (killed antigen) vaccines - WHO Vaccine Safety Basics". vaccine-safety-training.org. World Health Organization (WHO). 4 Kasım 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Kasım 2021.

who.int

WHO Expert Committee on Biological Standardization (19 Haziran 2019). "Influenza". World Health Organization (WHO). 22 Ekim 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Ekim 2021.

worldcat.org

Plotkin S, Orenstein WA, Offit PA, (Ed.) (2018). "Technologies for Making New Vaccines". Plotkin's vaccines (7.7isbn=978-0-323-39302-7 bas.). Philadelphia, PA: Elsevier. OCLC 989157433.
Hotez, Peter J.; Bottazzi, Maria Elena (27 Ocak 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55-64. doi:10.1146/annurev-med-042420-113212. ISSN 0066-4219. PMID 34637324. 15 Nisan 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Nisan 2022.